Lv4
460 积分 2021-06-08 加入
Phase III Trial of Standard-Dose Intravenous Cisplatin Plus Paclitaxel Versus Moderately High-Dose Carboplatin Followed by Intravenous Paclitaxel and Intraperitoneal Cisplatin in Small-Volume Stage III Ovarian Carcinoma: An Intergroup Study of the Gynecologic Oncology Group, Southwestern Oncology Group, and Eastern Cooperative Oncology Group
5小时前
待确认
A randomized phase 3 trial of intraperitoneal versus intravenous carboplatin with dose-dense weekly paclitaxel in patients with ovarian, fallopian tube, or primary peritoneal carcinoma (a GOTIC-001/JGOG-3019/GCIG, iPocc Trial) (LBA 3)
6小时前
已关闭
Impact of age, comorbidity, and treatment characteristics on survival in older women with advanced high grade epithelial ovarian cancer
2个月前
已完结
Cytoreductive surgery with or without hyperthermic intraperitoneal chemotherapy in patients with advanced ovarian cancer (OVHIPEC-1): final survival analysis of a randomised, controlled, phase 3 trial
6个月前
已完结
Cytoreductive surgery with or without hyperthermic intraperitoneal chemotherapy in advanced ovarian cancer
6个月前
已完结
Intraperitoneal chemotherapy for ovarian cancer using sustained-release implantable devices
6个月前
已完结
Role of intraperitoneal chemotherapy in ovarian cancer in the platinum-taxane-based era: A meta-analysis
6个月前
已完结
Intraperitoneal Chemotherapy
6个月前
已完结
Hyperthermic Intraperitoneal Chemotherapy for the Treatment of Epithelial Ovarian Cancer
6个月前
已完结
Intraperitoneal chemotherapy requires expertise and should be the standard of care for optimally surgically resected epithelial ovarian cancer patients
6个月前
已完结
皖公网安备34019202002308
